Personal information

Other IDs

SciProfiles: 1930954

Activities

Collapse all

Professional activities (1)

Navarrabiomed: Pamplona, Navarra, ES

2020-09-28 to 2024 | Pre doctoral student (OncoImmunology)
Membership
Source: Self-asserted source
Miriam Echaide

Works (8)

Towards an improved SARS-CoV-2 vaccine for vulnerable population

2024-11-08 | Dissertation or Thesis
DOI: 10.48035/Tesis/2454/52492
Source: check_circle
Crossref

Fractalkine in Health and Disease

International Journal of Molecular Sciences
2024-07-23 | Journal article
DOI: 10.3390/ijms25158007
Contributors: Claudia Rodriguez; Luisa Chocarro; Miriam Echaide; Karina Ausin; David Escors; Grazyna Kochan
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Current Indications and Future Landscape of Bispecific Antibodies for the Treatment of Lung Cancer

International Journal of Molecular Sciences
2023-06-07 | Journal article
DOI: 10.3390/ijms24129855
Contributors: Hugo Arasanz; Luisa Chocarro; Leticia Fernández-Rubio; Ester Blanco; Ana Bocanegra; Miriam Echaide; Ibone Labiano; Ana Elsa Huerta; Maria Alsina; Ruth Vera et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

mRNA Vaccines against SARS-CoV-2: Advantages and Caveats

International Journal of Molecular Sciences
2023-03-21 | Journal article
DOI: 10.3390/ijms24065944
Contributors: Miriam Echaide; Luisa Chocarro de Erauso; Ana Bocanegra; Ester Blanco; Grazyna Kochan; David Escors
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors

International Journal of Molecular Sciences
2023-01-31 | Journal article
DOI: 10.3390/ijms24032676
Contributors: Ester Blanco; Luisa Chocarro; Leticia Fernández-Rubio; Ana Bocanegra; Hugo Arasanz; Miriam Echaide; Maider Garnica; Sergio Piñeiro-Hermida; Grazyna Kochan; David Escors
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination

Cancers
2022-09-14 | Journal article
DOI: 10.3390/cancers14184464
Contributors: Miriam Echaide; Ibone Labiano; Marina Delgado; Angela Fernández de Lascoiti; Patricia Ochoa; Maider Garnica; Pablo Ramos; Luisa Chocarro; Leticia Fernández; Hugo Arasanz et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells

International Journal of Molecular Sciences
2022-08 | Journal article | Author
DOI: 10.3390/ijms23179880
Contributors: Anna AIELLO; Mattia Emanuela Ligotti; Maider Garnica; Giulia Accardi; Anna Calabrò; Fanny Pojero; Hugo Arasanz; Ana Isabel Bocanegra Gondan; Ester Blanco; Luisa Chocarro et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

How Can We Improve the Vaccination Response in Older People? Part II: Targeting Immunosenescence of Adaptive Immunity Cells

International Journal of Molecular Sciences
2022-08-29 | Journal article
DOI: 10.3390/ijms23179797
Contributors: Maider Garnica; Anna Aiello; Mattia Emanuela Ligotti; Giulia Accardi; Hugo Arasanz; Ana Bocanegra; Ester Blanco; Anna Calabrò; Luisa Chocarro; Miriam Echaide et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎
How many people are using ORCID?